Elevation of SCD1 activity is associated with increased obesity and the metabolic syndrome in humans [15, 16], while transgenic mice lacking SCD1 are protected from developing obesity induced insulin resistance [17, 18]. This evidence concerns the gene SCD and metabolic syndrome.